HomeAI · summaries
Storia in 2 fonti
Q&A: Lilly returns to neuropsych and looks ahead to Alzheimer's prevention
Lilly's Carole Ho talks blood tests for early Alzheimer's detection, the $2.8B AtaiBeckley psychedelics deal and Lilly's broader neuroscience push.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
Big Pharma And Psychedelic Medicine: Eli Lilly’s $3.8 Billion Bet
Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.
- ·
endpoints.news
Q&A: Lilly returns to neuropsych and looks ahead to Alzheimer's prevention
Lilly's Carole Ho talks blood tests for early Alzheimer's detection, the $2.8B AtaiBeckley psychedelics deal and Lilly's broader neuroscience push.